d’Orsi, G.; Liantonio, A.; Imbrici, P.; Gambacorta, N.; Dinoi, G.; Altomare, C.D.; DEFEAT-LD Study Group; Carella, M.
Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets. Methods Protoc. 2025, 8, 48.
https://doi.org/10.3390/mps8030048
AMA Style
d’Orsi G, Liantonio A, Imbrici P, Gambacorta N, Dinoi G, Altomare CD, DEFEAT-LD Study Group, Carella M.
Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets. Methods and Protocols. 2025; 8(3):48.
https://doi.org/10.3390/mps8030048
Chicago/Turabian Style
d’Orsi, Giuseppe, Antonella Liantonio, Paola Imbrici, Nicola Gambacorta, Giorgia Dinoi, Cosimo Damiano Altomare, DEFEAT-LD Study Group, and Massimo Carella.
2025. "Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets" Methods and Protocols 8, no. 3: 48.
https://doi.org/10.3390/mps8030048
APA Style
d’Orsi, G., Liantonio, A., Imbrici, P., Gambacorta, N., Dinoi, G., Altomare, C. D., DEFEAT-LD Study Group, & Carella, M.
(2025). Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets. Methods and Protocols, 8(3), 48.
https://doi.org/10.3390/mps8030048
